Next Live Webinars

Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug Formulations

Excipient impurities causing stability failures? Formulation inconsistencies delaying your launch? Visual quality issues impacting patient confidence?

Join the webinar to discover why excipient selection from day one is critical to your formulation success and how advanced purification technologies can eliminate the hidden risks that compromise drug product quality.

Excipient quality extends beyond compendial specifications. Explore smart selection strategies for complex formulations with poorly water-soluble APIs. Prevent impurity-driven interactions that compromise stability and ensure consistent performance through commercial scale. See breakthrough purification technology achieving up to 54% reduction in color formation while maintaining full functionality.

Why Attend?

Start right: Make informed excipient choices early in development
Reduce risk: Prevent stability failures and batch rejections
Accelerate timelines: Avoid costly reformulation and launch delays
Build confidence: Deliver consistent, high-quality products patients trust

Perfect For:

Formulation scientists
QA/Regulatory professionals
R&D managers
CMC specialists
Technical decision-makers in pharma and biopharma development

What you will learn:

How excipient impurities can influence drug product stability, discoloration, and degradation pathways
Practical strategies for selecting excipients in complex formulations, especially for poorly water-soluble APIs
How excipient purity impacts visual consistency, stability, and manufacturability of drug products
How advanced purification technologies can help mitigate formulation risks

Date & Time & Timezone: Apr 22, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

Speaker:

Dr. Bhushan Thekedar

Head of Global Business Development, Clariant

Dr. Bhushan Thekedar is Head of Global Business Development for Healthcare at Clariant, where he leads global commercial strategy and growth initiatives for pharmaceutical excipients.

With over 15 years of experience in the life sciences industry, he has held technical and commercial leadership roles at Clariant, Merck KGaA, and BASF, focusing on formulation excipients, bioavailability enhancement technologies, and pharmaceutical ingredient solutions.

Dr. Thekedar combines a strong scientific background with global business development expertise and works closely with pharmaceutical companies to support the development of robust and high-performance drug formulations.

For more information & registration here:

REGISTRATION

Lipid-based formulations and enteric capsules to enhance oral bioavailability of peptides

MORE INFORMATION & REGISTRATION

Join this webinar to discover how lipid-based formulations (LBFs) can help address the oral bioavailability challenges of peptide-based therapies.

It provides a practical overview of step-by-step LBF development and scientific data confirming the robust performance of Capsugel® Enprotect® capsules. Attendees will also learn how capsule features can be optimized to improve drug release profiles and formulation compatibility.

What you will learn:

Learn how lipid-based formulations (LBF) can help overcome key oral bioavailability challenges for peptides.
Understand a practical step-by-step approach to LBF development for oral peptide applications.
See how enteric capsules can protect large molecules from gastric degradation and offer consistent drug release through in vivo data

Perfect for: Formulation scientists and R&D manager

Date & Time & Timezone: Apr 28, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

Speaker:

Dr. Camille Dumont

Capsule Application Manager, Lonza Capsules and Health Ingredients

Camille Dumont is Capsule Application Manager at Lonza Capsugel, working within the Innovaform Accelerator team. In this role, she leads a team dedicated to developing custom formulations and assessing the pharmaceutical performance of capsules, with the goal of addressing complex drug delivery challenges through capsule innovation.

With over 10 years of experience in the pharmaceutical industry, Camille has developed deep expertise in creating advanced solutions to enhance drug bioavailability. Her particular focus lies in lipid-based formulations designed to improve the oral delivery of small molecules and peptides.

Camille holds a Master’s degree in Chemistry and Formulation and a PhD in Pharmaceutical Sciences from the University of Lyon.

For more information & registration here:

REGISTRATION

Nano-Formulations: Turning Insoluble APIs into Effective Dosage Forms

MORE INFORMATION & REGISTRATION

Presentation 1:

Wet nano milling for solubility enhancement

Nanoparticles offer significant benefits beyond solubility, including improved bioavailability and better dose response
Wet nano milling is a controlled, safe, and scalable process
Grinding bead and technology selection is decisive for successful milling

Presentation 2:

From nano to drug product: a case study

Key takeaways:

The downstream process of nanocrystals in a fluid bed provides a robust and scalable platform, also for high-loaded formulations, combining narrow particle size distribution, excellent redispersibility, and proven mid-term stability.

The downstream process in a fluid bed maintains a tight particle size distribution of nanocrystals with a low PDI, ensuring high batch consistency and uniformity.
The resulting particles are fully redispersible, preserving performance after reconstitution.
The system can support high drug loads, making it suitable for challenging formulations.
Current data indicate promising physical stability over at least 6 months, with longer-term studies still ongoing.

Date & Time & Timezone: Apr 29, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

Speaker:

Alexander Schmidt

Area Sales Manager, Willy A. Bachofen AG

Alexander Schmidt studied mechanical engineering and business administration after successfully completing his electromechanical apprenticeship.

Over the years, Alexander has gained a lot of experience in the fields of engineering and design / sales of equipment and solutions. He could apply his knowledge in various commissioning and start-up phases.

Since joining Willy A. Bachofen AG, he has completed a comprehensive training programme, gaining in-depth expertise in customer support and technical consulting. In his role as Area Sales Manager, Alexander is responsible for markets in Germany, Austria, Indonesia, Vietnam, Thailand, the Philippines, Australia and New Zealand.

As a solution-oriented expert in wet grinding technology, milling technology and flow chemistry, Alexander is the right contact person for all your questions.

Adèle Rakotonirina, PhD

Business Development Glatt Pharmaceutical Services, Glatt Pharmaceutical Services

Adèle Rakotonirina, PhD, is a pharmacist and formulation scientist with expertise in oral solid dosage form development and pharmaceutical innovation.

She currently works in Business Development at Glatt Pharmaceutical Services, where she supports partners from formulation development through commercialization. With a background spanning science, drug delivery, and science communication, she brings both technical expertise and commercial insight to the discussion.

For more information & registration here:

REGISTRATION